Home Privacy Archive Realtime Report

Stock Trading History of Saks Samuel R

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Saks Samuel R since year 2005. The trader's CIK number is 1365615. At the time of this reporting, Saks Samuel R is the Chief Executive Officer of Jazz Pharmaceuticals Inc (stock ticker symbol JAZZ).

Stock purchases, sales, and option exercises reported by *Saks Samuel R* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-11-14	JAZZ	Jazz Pharmaceuticals Inc	Purchase	4,900	13.39	65,611
2007-11-13	JAZZ	Jazz Pharmaceuticals Inc	Purchase	13,300	13.44	178,728
2007-11-12	JAZZ	Jazz Pharmaceuticals Inc	Purchase	10,438	13.37	139,513

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saks Samuel R (Chief Executive Officer of Jazz Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.